3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Hodgkin Disease
13
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia, Biphenotypic, Acute
8
Leukemia
8
Burkitt Lymphoma
7
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, Mantle-Cell
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Anemia, Refractory, with Excess of Blasts
4
Medulloblastoma
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Lenalidomide
7
Dexamethasone
5
daratumumab
4
Calcium Dobesilate
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
auricularum
3
Curcumin
3
isatuximab
2
iberdomide
2
Leflunomide
2
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
fludarabine phosphate
1
fludarabine
1
citarinostat
1
Watchful Waiting
1
Urination
1
Stem Cell Transplantation
1
Resistance Training
1
Propranolol
1
Probiotics
1
Peripheral Blood Stem Cell Transplantation
1
PVX-410 vaccine
1
Observation
1
Metformin
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
Filgrastim
×
1 year
×
Clear all
No trials found.